Post-procedural pain medication gets label extension from the FDAApril 12, 2024An extended-release buprenorphine injectable suspension indicated for mice, rats, ferrets, Ethiqa XR gets the U.S. Food and Drug Administration (FDA) green light for use in non-human primates (NHPs)
SPONSORED CONTENTHelping manage the hidden signs of stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More
Reconsidering antibiotic duration for canine aspiration pneumoniaMarch 29, 2024Extended antibiotic therapy is not an unreasonable idea. New research is whittling away the recommended duration of antibiotics for canine aspiration pneumonia. Is there, in fact, good evidence for recommendations for long duration of antibiotic therapy for aspiration pneumonia?
$45M additional funding bolsters development of canine longevity drugMarch 25, 2024The latest financing round brings the total funds raised for the first FDA-approved dog lifespan extension drug to $125M
The FDA reminds veterinarians, pet owners of recalled eye dropsMarch 13, 2024The agency reports receiving at least one ‘adverse event’ in an animal related to the use of these products.
Are you prescribing aconite (Monkshood, Wolf's Bane, Queen of Poisons)?February 24, 2024In the Chemistry World article titled, “The dead of aconite,”4 we learn that aconitine, an aconite alkaloid, is 100 times more lethal than strychnine.
VPN Plus+ ExclusiveCompounding benefits through medication form optionsFebruary 14, 2024Not only do the pet and owner benefit from the use of a compounding pharmacy, but the veterinary practice can, as well. When appropriate, compounding provides veterinarians and their teams with an opportunity to offer a solution for the pet owner to enhance the human-animal bond versus causing stress and anxiety for the pet and the owner. Compounding can also provide veterinary practices with innovative ways to provide additional services and increase customer loyalty.
Canine longevity drug starts clinical trialFebruary 1, 2024A whippet named Boo is the first dog dosed in the study to demonstrate healthy lifespan extension in dogs treated with LOY-002
Saving a million puppies from parvo aim of new multi-year campaignJanuary 15, 2024Elanco has launched the “Defend Puppies. Defeat Parvo.” at VMX 2024, encouraging veterinary professionals to ramp up client education about the deadly disease
A pharmaceutical approach to pain managementJanuary 9, 2024Recognizing, assessing, and treating pain is not only essential for the comfort and well-being of our patients, but also contributes to their overall recovery and quality of life.
North Carolina will soon mandate veterinarians to declare gabapentin useDecember 20, 2023As part of Gov. Roy Cooper’s North Carolina Opioid and Substance Use Action Plan, he signed into law this past June a new requirement to report the use of the pain management medication
